Monitor for additional draws under the facility, which would signal accelerating cash burn. The large undrawn $48.3M capacity plus the related-party lender relationship warrant close attention to future 10-Q for leverage and interest cost details. The first draw is too small to materially alter the balance sheet or cash runway outlook.
Price Chart
Executive Summary
TuHURA Biosciences drew $1.7M from its $50M revolving credit facility with Parkview Holdings One LLC, the first draw under the facility that matures April 2026. The minimal initial draw relative to the $50M capacity and use for general corporate purposes suggest modest near-term cash needs, but the existence of a large undrawn facility and related-party lender (affiliate of largest stockholder) introduce lingering capital structure and conflict-of-interest considerations.
Key Facts
- On May 26, 2026, TuHURA received its first draw of $1.7M under the $50M revolving credit facility entered into with Parkview Holdings One LLC on April 21, 2026.
- The facility matures on April 21, 2031.
- Proceeds are expected to be used for general corporate purposes.
- The lender, Parkview Holdings One LLC, is an affiliate of the Company's largest stockholder (per risk factor language in the filing).
Financial Impact
First draw of $1.7M; total facility capacity is $50M. No pricing terms (interest rate, fees) or specific financial covenants disclosed in this filing.
Risk Factors
- Related-party lender (affiliate of largest stockholder) introduces potential for conflicts of interest or unfavorable terms.
- Future draws could substantially increase leverage and interest burden.
- The $1.7M draw may be insufficient to fund operations if cash burn is high, necessitating additional capital raises or more draws.
- Forward-looking statements note risk that facility may be insufficient to fund operations and development programs as anticipated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-248640 |
| Document: 0001193125-26-248640-index-headers.html | 0001193125-26-248640 |
| Document: 0001193125-26-248640-index.html | 0001193125-26-248640 |
| Document: 0001193125-26-248640.txt | 0001193125-26-248640 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K | $1.78 | awaiting T+60 | — | $2.11 (+18.54%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.11 (+0.48%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.11 (+0.48%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.11 (+0.96%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.11 (−0.47%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.11 (−4.95%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.11 (−14.57%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.11 (−14.57%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.11 (−14.57%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.11 (−2.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers